CVA Family Office’s Elanco Animal Health ELAN Stock Holding History

CVA Family Office’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$16.7K	Sell	680 -102	-13%	-$2.36K	﹤0.01%	865
2026 Q1	$18.7K	Buy	782 +705	+916%	+$17.2K	﹤0.01%	812
2025 Q4	$1.74K	Hold	77	–	–	﹤0.01%	1022
2025 Q3	$1.55K	Hold	77	–	–	﹤0.01%	1041
2025 Q2	$1.1K	Buy	77 +27	+54%	+$316	﹤0.01%	1086
2025 Q1	$525	Buy	+50	New	+$566	﹤0.01%	1242
2024 Q3	–	Sell	-37	Closed	-$534	–	1294
2024 Q2	$534	Buy	+37	New	+$591	﹤0.01%	1180
2023 Q2	–	Sell	-400	Closed	-$3.76K	–	1025
2023 Q1	$3.76K	Buy	+400	New	+$4.72K	﹤0.01%	805
2022 Q4	–	Sell	-195	Closed	-$2K	–	961
2022 Q3	$2K	Buy	+195	New	+$3.41K	﹤0.01%	803
2022 Q1	–	Sell	-145	Closed	-$4K	–	957
2021 Q4	$4K	Buy	+145	New	+$4.51K	﹤0.01%	770
2021 Q2	–	Sell	-200	Closed	-$6K	–	953
2021 Q1	$6K	Buy	+200	New	+$6.15K	﹤0.01%	591

Other funds holding ELAN

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

CVA Family Office's ELAN Position: Q2 2026 in Review

CVA Family Office reduced its Elanco Animal Health (ELAN) stake by 13% in Q2 2026, selling an estimated $2.36K and leaving 680 shares worth $16.7K. The position accounts for ﹤0.01% of the portfolio, ranked #865.

CVA Family Office first reported a position in ELAN in Q1 2021 and has held it in 11 quarters since. The position peaked at $18.7K in Q1 2026. 523 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

CVA Family Office held 680 shares of Elanco Animal Health worth $16.7K as of Q2 2026.
CVA Family Office sold 102 Elanco Animal Health shares in Q2 2026, an estimated $2.36K.
Elanco Animal Health made up ﹤0.01% of CVA Family Office's portfolio in Q2 2026, its #865 holding.
CVA Family Office first reported a position in Elanco Animal Health in Q1 2021 and has held it in 11 quarters since.
CVA Family Office's Elanco Animal Health position peaked at $18.7K in Q1 2026.
523 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.